Abstract
Objective:
The authors' goal was to test the hypothesis of extrastriatal D(2) receptor selectivity as the mechanism of action of clozapine.
Method:
Positron emission tomography (PET) was used to examine extrastriatal as well as striatal dopamine D(2) receptor occupancy in four patients treated with clozapine and three patients treated with haloperidol. The reference radioligand [(11)C]raclopride was used for determination of D(2) receptor occupancy in the striatum. The radioligand [(11)C]FLB 457 was chosen for determination of D(2) receptor occupancy in the thalamus, the temporal cortex, and the frontal cortex.
Results:
In patients treated with haloperidol the D(2) receptor occupancy was high in all examined brain regions. In clozapine-treated patients the D(2) receptor occupancy was relatively low in both the striatum and the extrastriatal regions.
Conclusions:
The results from the present study give no support for the hypothesis of regional selectivity as the mechanism of action for clozapine.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antipsychotic Agents / metabolism
-
Antipsychotic Agents / pharmacology*
-
Antipsychotic Agents / therapeutic use*
-
Brain / diagnostic imaging*
-
Brain / drug effects*
-
Brain / metabolism
-
Clozapine / metabolism
-
Clozapine / pharmacology*
-
Clozapine / therapeutic use*
-
Corpus Striatum / diagnostic imaging
-
Corpus Striatum / drug effects
-
Corpus Striatum / metabolism
-
Female
-
Haloperidol / pharmacology
-
Haloperidol / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Pyrrolidines
-
Raclopride
-
Receptors, Dopamine D2 / drug effects*
-
Receptors, Dopamine D2 / metabolism*
-
Salicylamides
-
Schizophrenia / diagnostic imaging
-
Schizophrenia / drug therapy*
-
Schizophrenia / metabolism
-
Schizophrenia, Paranoid / diagnostic imaging
-
Schizophrenia, Paranoid / drug therapy
-
Schizophrenia, Paranoid / metabolism
-
Tomography, Emission-Computed / statistics & numerical data*
Substances
-
Antipsychotic Agents
-
Pyrrolidines
-
Receptors, Dopamine D2
-
Salicylamides
-
FLB 457
-
Raclopride
-
Clozapine
-
Haloperidol